R. Reisner

Cross‐validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics

M. Pfeilstöcker, H. Nowotny, T. Nösslinger, 1999, British journal of haematology.

Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution.

M. Pfeilstöcker, E. Koller, H. Nowotny, 2001, Blood.

The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML)

G. Webersinke, R. Kusec, U. Jäger, 2019, Wiener klinische Wochenschrift.

Erythropoietin for chemotherapy patient refusing blood transfusion

R. Heinz, R. Reisner, E. Pittermann, 1990, The Lancet.

All Trans Retinoic Acid in Primary and Relapsed Acute Promyelocytic Leukemia

R. Grill, E. Koller, O. Krieger, 1992 .

Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma

H. Kaufmann, J. Ackermann, J. Drach, 2003, European journal of haematology.

Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure

H. Greinix, A. Böhm, K. Gleixner, 2017, Journal of clinical apheresis.

Dysplastic versus proliferative CMML--a retrospective analysis of 91 patients from a single institution.

M. Pfeilstöcker, H. Nowotny, T. Nösslinger, 2001, Leukemia research.